Showing results (131-140 of 134) with videos related to
Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 134 results.
Nature Immunology|July 31, 2019
PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1+CD38hi cells and anti-PD-1 resistanceVivek Verma, Rajeev K Shrimali, Shamim Ahmad, et al.Nature Immunology|September 26, 2019
Author Correction: PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1+CD38hi cells and anti-PD-1 resistanceVivek Verma, Rajeev K Shrimali, Shamim Ahmad, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2026
Pemigatinib for Unresectable or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor-2 Rearrangement: Results From the Phase 3 FIGHT-302 TrialTanios S Bekaii-Saab, Davide Melisi, Hanneke Wilmink, et al.Proceedings of the National Academy of Sciences of the United States of America|October 7, 2015
90Y-daclizumab, an anti-CD25 monoclonal antibody, provided responses in 50% of patients with relapsed Hodgkin's lymphomaJohn E Janik, John C Morris, Deirdre O'Mahony, et al.Pageof 14